Related Experiment Video
Updated: Apr 27, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation
April Reynolds1, Elizabeth A Doggett1, Steve M Riddle2
1Parkinson's Institute Sunnyvale, CA, USA.
Abstract:
Missense mutations in the Leucine-Rich Repeat protein Kinase 2 (LRRK2) gene are the most common genetic predisposition to develop Parkinson's disease (PD) (Farrer et al., 2005; Skipper et al., 2005; Di Fonzo et al., 2006; Healy et al., 2008; Paisan-Ruiz et al., 2008; Lesage et al., 2010). LRRK2 is a large multi-domain phosphoprotein with a GTPase domain and a serine/threonine protein kinase domain whose activity is implicated in neuronal toxicity; however the precise mechanism is unknown. LRRK2 autophosphorylates on several serine/threonine residues across the enzyme and is found constitutively phosphorylated on Ser910, Ser935, Ser955, and Ser973, which are proposed to be regulated by upstream kinases. Here we investigate the phosphoregulation at these sites by analyzing the effects of disease-associated mutations Arg1441Cys, Arg1441Gly, Ala1442Pro, Tyr1699Cys, Ile2012Thr, Gly2019Ser, and Ile2020Thr. We also studied alanine substitutions of phosphosite serines 910, 935, 955, and 973 and specific LRRK2 inhibition on autophosphorylation of LRRK2 Ser1292, Thr1491, Thr2483 and phosphorylation at the cellular sites. We found that mutants in the Roc-COR domains, including Arg1441Cys, Arg1441His, Ala1442Pro, and Tyr1699Cys, can positively enhance LRRK2 kinase activity, while concomitantly inducing the dephosphorylation of the cellular sites. Mutation of the cellular sites individually did not affect LRRK2 intrinsic kinase activity; however, Ser910/935/955/973Ala mutations trended toward increased kinase activity of LRRK2. Increased cAMP levels did not lead to increased LRRK2 cellular site phosphorylation, 14-3-3 binding or kinase activity. In cells, inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser1292 by Calyculin A and Okadaic acid sensitive phosphatases, while the cellular sites are dephosphorylated by Calyculin A sensitive phosphatases. These findings indicate that comparative analysis of both Ser1292 and Ser910/935/955/973 phosphorylation sites will provide important and distinct measures of LRRK2 kinase and biological activity in vitro and in vivo.
Insights
Parkinson's disease (PD) genetics reveal that Leucine-Rich Repeat protein Kinase 2 (LRRK2) mutations enhance kinase activity and alter cellular phosphorylation. Analyzing LRRK2 phosphosites offers distinct measures of its biological activity.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Missense mutations in the Leucine-Rich Repeat protein Kinase 2 (LRRK2) gene are a primary genetic risk factor for Parkinson's disease (PD).
- LRRK2, a serine/threonine kinase, is implicated in neuronal toxicity, but its precise pathogenic mechanisms remain unclear.
- LRRK2 exhibits autophosphorylation and is constitutively phosphorylated at specific cellular sites (Ser910, Ser935, Ser955, Ser973), potentially regulated by upstream kinases.
Purpose of the Study:
- To investigate the phosphoregulation of LRRK2 at key sites in response to disease-associated mutations and specific inhibitors.
- To analyze the impact of mutations in the Roc-COR domains and alanine substitutions of phosphosites on LRRK2 kinase activity.
- To elucidate the distinct roles of Ser1292 and cellular site phosphorylation in measuring LRRK2 activity.
Main Methods:
- Analysis of disease-associated LRRK2 mutations (e.g., Arg1441Cys, Gly2019Ser) and alanine substitutions at phosphosites (Ser910, 935, 955, 973).
- Assessment of LRRK2 autophosphorylation at Ser1292 and cellular site phosphorylation under various conditions, including LRRK2 inhibition.
- Investigation of the effects of increased cAMP levels and specific phosphatases (Calyculin A, Okadaic acid) on LRRK2 phosphorylation.
Main Results:
- Roc-COR domain mutants (e.g., Arg1441Cys, Tyr1699Cys) enhance LRRK2 kinase activity and induce dephosphorylation of cellular sites.
- While individual cellular site mutations had no effect, Ser910/935/955/973Ala mutations showed a trend toward increased LRRK2 kinase activity.
- LRRK2 kinase inhibition dephosphorylated Ser1292, while cellular sites were dephosphorylated by Calyculin A-sensitive phosphatases.
Conclusions:
- Specific LRRK2 mutations can modulate its kinase activity and affect cellular phosphorylation patterns.
- Phosphorylation at Ser1292 and the cellular sites (Ser910/935/955/973) represent distinct and valuable indicators of LRRK2 activity.
- Comparative analysis of these phosphorylation sites provides a comprehensive understanding of LRRK2's biological function in vitro and in vivo.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cell Signaling in Plants

